These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17432564)

  • 1. Prostate cancer treatment and quality of life.
    Prezioso D; Galasso R; Di Martino M; Iapicca G
    Recent Results Cancer Res; 2007; 175():251-65. PubMed ID: 17432564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose?
    van den Bergh RC; de Blok W; van Muilekom E; Tillier C; Venderbos LD; van der Poel HG
    Scand J Urol; 2014 Aug; 48(4):367-73. PubMed ID: 24506062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of quality-of-life evaluations in prostate cancer.
    Sommers SD; Ramsey SD
    Pharmacoeconomics; 1999 Aug; 16(2):127-40. PubMed ID: 10539394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
    Lilleby W; Fosså SD; Waehre HR; Olsen DR
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5.
    Jønler M; Nielsen OS; Groenvold M; Hedlund PO; Damber L; Hedelin H; Waldén M;
    Scand J Urol Nephrol; 2005; 39(1):42-8. PubMed ID: 15764270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporal changes in quality of life after prostate carcinoma].
    Perl M; Waldmann A; Pritzkuleit R; Katalinic A
    Urologe A; 2012 May; 51(5):706-12. PubMed ID: 22278167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and economic considerations in the management of prostate cancer.
    Turini M; Redaelli A; Gramegna P; Radice D
    Pharmacoeconomics; 2003; 21(8):527-41. PubMed ID: 12751912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study.
    Siston AK; Knight SJ; Slimack NP; Chmiel JS; Nadler RB; Lyons TM; Kuzel TM; Moran EM; Sharifi R; Bennett CL;
    Urology; 2003 Jan; 61(1):172-8. PubMed ID: 12559291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments.
    Protopapa E; van der Meulen J; Moore CM; Smith SC
    BJU Int; 2017 Oct; 120(4):468-481. PubMed ID: 28437031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the German prostate-specific module.
    Bestmann B; Rohde V; Siebmann JU; Galalae R; Weidner W; Küchler T
    World J Urol; 2006 Feb; 24(1):94-100. PubMed ID: 16421733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual quality of life following radical prostatectomy in men with prostate cancer.
    Willener R; Hantikainen V
    Urol Nurs; 2005 Apr; 25(2):88-90, 95-100. PubMed ID: 15900977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.
    Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y
    J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer.
    Lehto US; Ojanen M; Väkevä A; Dyba T; Aromaa A; Kellokumpu-Lehtinen P
    Qual Life Res; 2019 Mar; 28(3):677-686. PubMed ID: 30511254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
    Lubeck DP; Grossfeld GD; Carroll PR
    Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.